These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 6490224

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D, Molz KH, Staib AH, Rietbrock N.
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Bioavailability of 3 theophylline delayed-release preparations. Comparison of theophylline concentrations in the serum and saliva in the steady state].
    Bochsler HP, Meyer UA.
    Schweiz Med Wochenschr; 1982 Nov 20; 112(47):1702-10. PubMed ID: 7178872
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of 2 theophylline delayed-action preparations of different galenic forms].
    Hirsch H.
    Wien Med Wochenschr; 1983 Aug 31; 133(15-16):403-8. PubMed ID: 6636797
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of steady state serum theophylline concentrations in healthy volunteers after dosing with Euphyllin retard and PulmiDur.
    Karlsson S, Lührmann B, Bahner ML, Schulz HU.
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun 31; 25(6):342-6. PubMed ID: 3623739
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM, Weinstein DB, Watts MT, Seifert B.
    Clin Ther; 1986 Jun 31; 8(2):175-80. PubMed ID: 3698064
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis.
    van der Vet AP, Kreukniet J, Drost RH, Maes RA, Fokkens JK, Hamelink ML.
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct 31; 24(10):569-73. PubMed ID: 3023243
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum theophylline levels in asthmatic children receiving sustained-release theophylline tablets.
    Kelly HW, Murphy S.
    Am J Hosp Pharm; 1979 Dec 31; 36(12):1698-701. PubMed ID: 525646
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1998 Aug 31; 473():1-326. PubMed ID: 12571677
    [Abstract] [Full Text] [Related]

  • 20. [The bioavailability of 4 sustained-release theophylline preparations from the Chilean market].
    Biagini L, Zamora P, Chávez H, Saavedra I.
    Rev Med Chil; 1990 Nov 31; 118(11):1241-6. PubMed ID: 2152650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.